Increasing Prevalence of Vitamin Deficiency is Expected to Propel the Growth of the Global Multivitamin Capsules & Tablets Market at a CAGR of 6.33% During the Review Period

Multivitamin Capsules & Tablets Market is predicted to reach USD 21,826.4 Million at a CAGR of 8.20% during the forecast period:

Market Research Future (MRFR) has published a cooked research report on the “Multivitamin Capsules & Tablets Market” that contains information from 2018 to 2030. The Multivitamin Capsules & Tablets Market is estimated to register a CAGR of 8.20% during the forecast period of 2023 to 2030.

MRFR recognizes the following companies as the key players in the global Multivitamin Capsules & Tablets Market — Glanbia PLC, Amway Corp., Abbott, Pfizer Inc., Bayer AG, ADM, GlaxoSmithKline plc, Nu Skin, Enterprises, Inc., Bionova, Arkopharma, Ayanda, Nature's Sunshine Products, Inc., and Herbalife International of America, Inc.

Multivitamin Capsules Tablets Market Highlights

The global Multivitamin Capsules & Tablets Market is accounted to register a CAGR of 8.20% during the forecast period and is estimated to reach USD 21,826.4 Million by 2030.

the Multivitamin Capsules & Tablets market refers to the global industry centered around the production, distribution, and sale of Multivitamin Capsules & Tablets supplements. Multivitamin Capsules & Tabletss are dietary supplements that contain a combination of vitamins, minerals, and sometimes other nutrients, intended to supplement the daily intake of these essential nutrients that may be lacking in a person's diet.

Segment Analysis

The global Multivitamin Capsules & Tablets Market has been segmented based on Type, and Distribution Channel.

The Multivitamin Capsules & Tablets segment dominated the market and accounted for over 40.0% share of the global revenue in 2020. Multivitamin Capsules & Tablets supplements comprise a combination of minerals and vitamins and at times other ingredients too. According to the World Health Organization, over 2 billion people worldwide suffer from vitamin and mineral deficiencies. Many athletes need Multivitamin Capsules & Tablets supplements to perform their best, which provide complete nutrients to maintain energy levels.

The offline segment dominated the market and held a revenue share of over 75.0% in 2020. In the offline segment, the hypermarkets/supermarkets segment captured the largest revenue share of more than 40.0% in 2020. A separate section or shelf for wellness products in hypermarkets and supermarkets enables customers to easily identify their desired brand, which is a key factor propelling the market growth.

Regional Analysis

The global Multivitamin Capsules & Tablets Market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. The European region was responsible for a significant share of revenue in 2020 and is expected to expand at a growth rate of 6.8% above forecast figure. Increased consumer awareness and higher disposable income per capita in developed countries, such as the United Kingdom, France and Germany are expected to boost the regional market during the forecast.

Asia-Pacific expects significant growth during the forecast. The market is expected to be the largest market in the region by 2025 due to growing consumerism in countries, including South Korea, India and China . The increase in per capita income, the raising awareness and increased spending on products that improve health in the region should motivate dietary supplements during the projected period.

North America became the most important market in the region with 35.7% revenue by 2020 due to increased consumption of low-calorie and nutritious foods. In addition to the growing awareness of the consumption of supplement products in Mexico due to the launch of new products awaits the rise in demand for dietary supplements during the forecast period.

Key Findings of the Study

• The global Multivitamin Capsules & Tablets Market is expected to reach USD 21,826.4 Million by 2030, at a CAGR of 8.20% during the forecast period.


• The European region was responsible for a significant share of revenue in 2020 and is expected to expand at a growth rate of 6.8% above forecast figure. Increased consumer awareness and higher disposable income per capita in developed countries, such as the United Kingdom, France and Germany are expected to boost the regional market during the forecast.


• The Multivitamin Capsules & Tablets segment dominated the market and accounted for over 40.0% share of the global revenue in 2020. Multivitamin Capsules & Tablets supplements comprise a combination of minerals and vitamins and at times other ingredients too.


• Glanbia PLC, Amway Corp., Abbott, Pfizer Inc., Bayer AG, ADM, GlaxoSmithKline plc, Nu Skin, Enterprises, Inc., Bionova, Arkopharma, Ayanda, Nature's Sunshine Products, Inc., and Herbalife International of America, Inc.